GNTbm Showcases Breakthrough Epigenetic Immune Activator at ASCO 2025
May 23, 2025 | 09:00
Promising preclinical data for GNTnm-38 hints at a new frontier in cancer immunotherapy.
Eisai Highlights E7386 in Collaboration with PRISM BioLab at ASCO 2025
May 23, 2025 | 08:00
The latest oncology pipeline advancement underscores a growing East-West research synergy.
Innovent to Showcase Breakthrough Clinical Data at ASCO 2025
April 24, 2025 | 14:20
Seven oral presentations will unveil novel immunotherapy insights, including IBI363, at one of oncology’s biggest global stages.
Mobile Version